Your cart is empty.
Maennedorf, Switzerland, December 3, 2019 – Tecan is delighted to announce that the recently launched Spark® Cyto plate reader has been recognized at the prestigious 2019 Life Science Industry Awards. This unique system – which combines the flexibility of a high-end multimode plate reader with whole well imaging and comprehensive environmental control for cell-based assays – won the Silver prize in the Most Innovative New Cell Biology Product of 2019 category.
Spark Cyto is the first live cell plate reader to offer real-time detection and image analysis of biological, chemical and physical events, capturing the maximum amount of data from every well, at the same time and under the same conditions. It uses top-of-the-range camera components and a patent-pending LED autofocus system to provide real-time data acquisition and analysis – for 6- to 384-well formats – ensuring that no key event is ever missed. Its powerful SparkControl™ and Image Analyzer™ software give the operator control of key experimental parameters, allowing qualitative and quantitative information to be integrated into unique multiparametric data sets to deliver meaningful insights faster than ever before. Together with user-programmable advanced features – such as Real Time Experimental Control (REC™) for automatic performance of kinetic experiments – this unlocks new possibilities for cell-based research.
Dr. Klaus Lun, Executive Vice President, Head of the Life Sciences Business Division at Tecan, commented: “We are very happy that the Spark Cyto has been chosen as one of the most innovative cell biology products launched in 2019. Chosen by a panel of industry experts, this award recognizes the system’s potential for furthering cell biology research in a wide range of fields.”
To learn more about Tecan’s Spark Cyto, go to www.tecan.com/sparkcyto.
For more information please contact
Tecan Trading AG
Tel +41 (0)44 922 81 11
Fax +41 (0)44 922 81 12
Tecan (www.tecan.com) is a leading global provider of laboratory instruments and solutions in biopharmaceuticals, forensics and clinical diagnostics. The company specializes in the development, production and distribution of automated workflow solutions for laboratories in the life sciences sector. Its clients include pharmaceutical and biotechnology companies, university research departments, forensic and diagnostic laboratories. As an original equipment manufacturer (OEM), Tecan is also a leader in developing and manufacturing OEM instruments and components that are then distributed by partner companies. Founded in Switzerland in 1980, the company has manufacturing, research and development sites in both Europe and North America and maintains a sales and service network in 52 countries. In 2018, Tecan generated sales of CHF 594 million (USD 606 million; EUR 516 million). Registered shares of Tecan Group are traded on the SIX Swiss Exchange (TECN; ISIN CH0012100191).